In this regard, TGF-β treatment down-regulates c-Myc in hepatocytes [79] and in well-differentiated hepatocellular carcinoma (HCC) cell lines in a Smad dependent manner [80,81]. This evidence concerns the gene MYC and hepatocellular carcinoma.